CYRANO THERAPEUTICS

cyrano-therapeutics-logo

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell. The company's product (CYR-001) repurposes an approved molecule (Theophylline) for this new indication and has been tested with success in a pilot study. Eight out of the 10 patients treated had significant improvement in taste and smell within 2 weeks with no reported side effects. The primary treatment provider will be the Otolaryngologist (Ear, Nose, and Throat specialist) and credible clinical investigators in this specialty have been identified and have expressed interest in participating in the clinical program. Cyrano Therapeutics was founded in 2014 and is headquartered in Washington, DC, USA.

#SimilarOrganizations #People #Financial #Website #More

CYRANO THERAPEUTICS

Social Links:

Industry:
Health Care Medical Medical Device Therapeutics

Founded:
2014-01-01

Address:
Washington, District Of Columbia, United States

Country:
United States

Website Url:
http://www.cyranotherapeutics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
12.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail


Similar Organizations

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

viking-therapeutics-logo

Viking Therapeutics

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.


Current Advisors List

not_available_image

Taka Koda Board Member @ Cyrano Therapeutics
Board_member
2020-12-01

gerry-brunk-mba_image

Gerry Brunk, MBA Board Member @ Cyrano Therapeutics
Board_member
2020-12-01

Current Employees Featured

not_available_image

Robert Henkin
Robert Henkin Founder @ Cyrano Therapeutics
Founder

rick-geoffrion_image

Rick Geoffrion
Rick Geoffrion President and CEO @ Cyrano Therapeutics
President and CEO
2019-05-01

Founder


not_available_image

Robert Henkin

Investors List

remiges-ventures_image

Remiges Ventures

Remiges Ventures investment in Series A - Cyrano Therapeutics

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series A - Cyrano Therapeutics

Official Site Inspections

http://www.cyranotherapeutics.com

  • Host name: 244.0.153.160.host.secureserver.net
  • IP address: 160.153.0.244
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Cyrano Therapeutics" on Search Engine